커넥티드 의료기기 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the connected medical devices market size was valued at USD 75.99 billion in 2025 and estimated to grow from USD 87.17 billion in 2026 to reach USD 173.26 billion by 2031, at a CAGR of 14.72% during the forecast period (2026-2031).

This report is Segmented by Connectivity Technology (Wi-Fi, BLE, NFC, Zigbee, Cellular, LPWAN, Satellite IoT), Device Type (Wearable, Implantable, Stationary, Disposable Sensors, Portable Tools), Application (Clinical Operations, Imaging, Medication Management, and More), End User (Hospitals, Home-Care, Patients, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Connected Medical Device Market Trends and Insights

Expansion of Real-Time Patient Monitoring via RPM Reimbursement

Medicare's 2024 decision to widen billing codes 99453-99458 created a dependable revenue path that convinced health systems to scale continuous monitoring programs for high-risk chronic cohorts.Device makers that can document reduced readmissions now enjoy accelerated value-analysis approvals, especially for diabetes and cardiac applications where outcomes are easily quantified. Pay-for-performance incentives are cascading to private payers, further boosting unit demand as providers seek turnkey platforms that integrate devices, dashboards, and clinical services. The resulting uptick in Connected Medical Devices market orders is strongest among integrated delivery networks that bear shared savings risk.

Falling Sensor and Connectivity Costs Enabling Device Miniaturization

MEMS component prices have declined roughly 15-20% a year since 2020, allowing suppliers to pack multiple sensing modalities into postage-stamp-sized packages and still protect margins. Abbott's FreeStyle Libre 3 sensor, currently one of the smallest mass-produced devices in its class, illustrates how suppliers are translating cost curves into discreet wearables with 14-day battery life. Lower bill-of-materials costs expand eligibility in public procurement tenders across Asia-Pacific, where cost-effectiveness benchmarks remain stringent. Smaller footprints also drive adherence gains because patients can wear devices unobtrusively during daily routines, reinforcing long-term retention in subscription monitoring programs.

Legacy Proprietary Platforms Hindering Interoperability

Hospitals that still run siloed bedside monitors face double-entry workflow and steep integration fees whenever a new connected module is introduced. Although HL7 FHIR promises data liquidity, uneven vendor adoption forces providers to rely on middleware that drives up total cost of ownership and slows refresh cycles. Procurement teams, wary of stranded-asset risk, often restrict tenders to suppliers with proven open-API roadmaps, limiting market access for niche innovators and tempering broader Connected Medical Devices market growth.

Other drivers and restraints analyzed in the detailed report include:

1. 5G and LPWAN Deployment Unlocking Ultra-Low-Latency Clinical Use Cases
2. AI-Powered Predictive Analytics Improving Device Value Proposition
3. Rising Cybersecurity Breaches Targeting IoMT Endpoints

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, Wi-Fi accounted for 42.78% of the Connected Medical Devices market share because most acute-care facilities already possess enterprise WLAN architectures. The same year, 5G began its breakout trajectory, fueled by telecom capital spending that reached USD 140 billion across Asia-Pacific. Ultra-low latency gives electrophysiology labs confidence to stream HD cardiac mapping data for off-site consultation, while LPWAN modules shrink battery packs in neonatal monitors to fit inside wearable swaddles. Satellite IoT backfills outages during disaster-response missions, ensuring 99.999% uptime mandated in trauma-center service-level agreements.

Accelerated 5G adoption signals a structural pivot in the Connected Medical Devices market from fixed stations toward location-agnostic analytics platforms. As spectrum licenses migrate to open-RAN frameworks, device makers gain flexibility to embed carrier-agnostic SIMs that auto-provision in multiple jurisdictions, streamlining global product launches. Regulatory alignment under ITU guidelines curbs custom radio-frequency testing, trimming certification lead times by up to three months and expediting entry in the fastest-growing export markets.

Wearable external devices controlled 62.88% of the Connected Medical Devices market share in 2025, underpinned by consumer familiarity with smartwatch interfaces. Implantable smart pumps, however, are on track for an 18.12% CAGR as wireless charging pads lengthen replacement intervals and bioresorbable casings ease surgical removal anxiety. Disposable ingestibles occupy a tactical niche for short-horizon infection surveillance during chemotherapy cycles, whereas stationary monitors remain indispensable for telemetry wards that demand waveform fidelity exceeding consumer-grade specifications.

Implantables appeal to payers because continuous dose-adjusting algorithms can cut drug wastage by double digits, delivering quantifiable savings that justify higher upfront capital outlays. Wearable makers, meanwhile, are scaling cloud subscription tiers that bundle algorithm updates, secure storage, and multilingual coaching to lock in annuity revenue. Over time, miniaturization advances are expected to blur category boundaries, birthing semi-implantable patches that combine the self-administration ease of wearables with the adherence benefits of fully embedded systems.

Complete Report Scope:

• By Connectivity Technology
  • Wi-Fi
  • Bluetooth Low Energy (BLE)
  • Near-Field Communication (NFC)
  • Zigbee
  • Cellular (3G/4G/5G and LPWAN)
  • Other LPWAN
  • Satellite IoT
• By Device Type
  • Wearable External Devices
  • Implantable Devices
  • Stationary Devices
  • Disposable / Ingestible Sensors
  • Portable Diagnostic Tools
• By Application
  • Remote Patient Monitoring
  • Clinical Operations and Workflow Management
  • Connected Imaging
  • Medication Management
  • Tele-ICU / Interactive Medicine
  • Preventive and Wellness Programs
• By End User
  • Hospitals and Health Systems
  • Ambulatory Surgical Centers
  • Home-Care Settings
  • Patients/Consumers
  • Research and Diagnostic Laboratories
  • Payers/Insurance Providers
  • Government and Defense Institutions
  • Other End Users
• By Geography
  • North America
    • United States
    • Canada
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia and New Zealand
    • Rest of Asia Pacific
  • Middle East and Africa
    • Middle East
      • GCC
      • Turkey
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Nigeria
      • Kenya
      • Rest of Africa

Geography Analysis

North America commanded 40.42% of 2025 revenue thanks to Medicare coverage expansion and FDA fast-track pathways that lowered approval times for AI-enabled devices. High EHR penetration and robust private-payer reimbursement let providers integrate new sensors without complex interface redevelopment, reinforcing regional adoption speed. The region also hosts the largest installed base of 5G-ready hospital campuses, giving suppliers an ideal launchpad for low-latency applications such as robotic bronchoscopy guidance.

Asia-Pacific is the fastest-growing territory, registering a 26.58% CAGR through 2031 on the back of USD 140 billion in healthcare digitization programs and regulatory harmonization under the International Medical Device Regulators Forum. China's streamlined priority-review channel has slashed approval timelines for innovative cardiology devices, stimulating domestic R and D investment and luring multinational joint ventures. In India, public-private partnerships are underwriting tele-ICU pilots across tier-2 cities, validating Connected Medical Devices market economics in value-constrained settings.

Europe shows steady expansion as the Medical Device Regulation enforces a single conformity framework, allowing vendors to amortize compliance costs over a larger addressable base. However, tougher clinical-evidence thresholds elongate dossier preparation, prompting many SMEs to seek notified-body slots two years in advance to avoid bottlenecks. Middle East and Africa and South America still trail on absolute spending but are fast upgrading telecom infrastructure, particularly in oil-funded Gulf states and Brazil's primary-care revamp, creating emerging pockets of high growth for telemetry solutions.

1. Medtronic plc
2. Koninklijke Philips N.V.
3. Boston Scientific Corporation
4. Abbott Laboratories
5. Garmin Ltd.
6. BIOTRONIK SE and Co. KG
7. Honeywell International Inc.
8. Stanley Black and Decker, Inc. (Stanley Healthcare)
9. NXP Semiconductors N.V.
10. GE HealthCare Technologies Inc.
11. Siemens Healthineers AG
12. DexCom, Inc.
13. Omron Healthcare Co., Ltd.
14. Masimo Corporation
15. ResMed Inc.
16. Teladoc Health, Inc.
17. Cisco Systems, Inc.
18. Hill-Rom Holdings, Inc.
19. Capsule Technologies, Inc.
20. Oracle Cerner Corporation
21. Apple Inc.
22. Fitbit LLC
23. AliveCor, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Expansion of real-time patient monitoring via RPM reimbursement
  • 4.2.2 Falling sensor and connectivity costs enabling device miniaturization
  • 4.2.3 5G and LPWAN deployment unlocking ultra-low-latency clinical use cases
  • 4.2.4 AI-powered predictive analytics improving device value proposition
  • 4.2.5 Shift to home-based chronic care amid hospital cAsia Pacificity constraints
  • 4.2.6 Institutional demand for interoperable data to optimize workflows
• 4.3 Market Restraints
  • 4.3.1 Legacy proprietary platforms hindering interoperability
  • 4.3.2 Rising cybersecurity breaches targeting IoMT endpoints
  • 4.3.3 Regulatory complexity and proof-of-safety costs for new device classes
  • 4.3.4 Bandwidth and power limitations in rural/underserved regions
• 4.4 Value/Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers/Consumers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitute Products
  • 4.7.5 Intensity of Competitive Rivalry
• 4.8 Connectivity Technology Landscape
  • 4.8.1 Wi-Fi
  • 4.8.2 Bluetooth Low Energy (BLE)
  • 4.8.3 Near-Field Communication (NFC)
  • 4.8.4 Zigbee
  • 4.8.5 Cellular (3G/4G/5G and LPWAN)

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Connectivity Technology
  • 5.1.1 Wi-Fi
  • 5.1.2 Bluetooth Low Energy (BLE)
  • 5.1.3 Near-Field Communication (NFC)
  • 5.1.4 Zigbee
  • 5.1.5 Cellular (3G/4G/5G and LPWAN)
  • 5.1.6 Other LPWAN
  • 5.1.7 Satellite IoT
• 5.2 By Device Type
  • 5.2.1 Wearable External Devices
  • 5.2.2 Implantable Devices
  • 5.2.3 Stationary Devices
  • 5.2.4 Disposable / Ingestible Sensors
  • 5.2.5 Portable Diagnostic Tools
• 5.3 By Application
  • 5.3.1 Remote Patient Monitoring
  • 5.3.2 Clinical Operations and Workflow Management
  • 5.3.3 Connected Imaging
  • 5.3.4 Medication Management
  • 5.3.5 Tele-ICU / Interactive Medicine
  • 5.3.6 Preventive and Wellness Programs
• 5.4 By End User
  • 5.4.1 Hospitals and Health Systems
  • 5.4.2 Ambulatory Surgical Centers
  • 5.4.3 Home-Care Settings
  • 5.4.4 Patients/Consumers
  • 5.4.5 Research and Diagnostic Laboratories
  • 5.4.6 Payers/Insurance Providers
  • 5.4.7 Government and Defense Institutions
  • 5.4.8 Other End Users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
  • 5.5.2 South America
    • 5.5.2.1 Brazil
    • 5.5.2.2 Argentina
    • 5.5.2.3 Rest of South America
  • 5.5.3 Europe
    • 5.5.3.1 Germany
    • 5.5.3.2 United Kingdom
    • 5.5.3.3 France
    • 5.5.3.4 Italy
    • 5.5.3.5 Spain
    • 5.5.3.6 Russia
    • 5.5.3.7 Rest of Europe
  • 5.5.4 Asia Pacific
    • 5.5.4.1 China
    • 5.5.4.2 Japan
    • 5.5.4.3 India
    • 5.5.4.4 South Korea
    • 5.5.4.5 Australia and New Zealand
    • 5.5.4.6 Rest of Asia Pacific
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 Middle East
      • 5.5.5.1.1 GCC
      • 5.5.5.1.2 Turkey
      • 5.5.5.1.3 Israel
      • 5.5.5.1.4 Rest of Middle East
    • 5.5.5.2 Africa
      • 5.5.5.2.1 South Africa
      • 5.5.5.2.2 Nigeria
      • 5.5.5.2.3 Kenya
      • 5.5.5.2.4 Rest of Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.4.1 Medtronic plc
  • 6.4.2 Koninklijke Philips N.V.
  • 6.4.3 Boston Scientific Corporation
  • 6.4.4 Abbott Laboratories
  • 6.4.5 Garmin Ltd.
  • 6.4.6 BIOTRONIK SE and Co. KG
  • 6.4.7 Honeywell International Inc.
  • 6.4.8 Stanley Black and Decker, Inc. (Stanley Healthcare)
  • 6.4.9 NXP Semiconductors N.V.
  • 6.4.10 GE HealthCare Technologies Inc.
  • 6.4.11 Siemens Healthineers AG
  • 6.4.12 DexCom, Inc.
  • 6.4.13 Omron Healthcare Co., Ltd.
  • 6.4.14 Masimo Corporation
  • 6.4.15 ResMed Inc.
  • 6.4.16 Teladoc Health, Inc.
  • 6.4.17 Cisco Systems, Inc.
  • 6.4.18 Hill-Rom Holdings, Inc.
  • 6.4.19 Capsule Technologies, Inc.
  • 6.4.20 Oracle Cerner Corporation
  • 6.4.21 Apple Inc.
  • 6.4.22 Fitbit LLC
  • 6.4.23 AliveCor, Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-space and Unmet-Need Assessment